EphA3 targeting reduces in vitro adhesion and invasion and in vivo growth and angiogenesis of multiple myeloma cells

被引：0

作者：

Francesco La Rocca

Irma Airoldi

Emma Di Carlo

Pina Marotta

Geppino Falco

Vittorio Simeon

Ilaria Laurenzana

Stefania Trino

Luciana De Luca

Katia Todoerti

Oreste Villani

Martin Lackmann

Fiorella D’Auria

Francesco Frassoni

Antonino Neri

Luigi Del Vecchio

Pellegrino Musto

Daniela Cilloni

Antonella Caivano

机构：

[1] IRCCS,Laboratory of Pre

[2] Referral Cancer Center of Basilicata (CROB),clinical and Translational Research

[3] IRCCS - G. Gaslini Institute,Laboratorio di Oncologia

[4] “G. D’Annunzio” University,Ce.S.I.

[5] Istituto di Ricerche Genetiche Gaetano Salvatore Biogem scarl,MeT, Aging Research Center, Pathological Anatomy and Immuno

[6] University of Naples “Federico II”,Oncology Unit, and Department of Medicine and Sciences of Aging

[7] Department of Onco-Hematology,Department of Stem Cell and Development

[8] IRCCS-CROB,Department of Biology

[9] Monash University,Department of Biochemistry and Molecular Biology

[10] Laboratory of Clinical Research and Advanced Diagnostics,Laboratorio Cellule Staminali post

[11] IRCCS-CROB,natali e Terapie Cellulari

[12] IRCCS - G. Gaslini Institute,Department of Clinical Sciences and Community Health, University of Milan and Hematology, Fondazione Cà Granda

[13] Ospedale Maggiore Policlinico,Department of Molecular Medicine and Medical Biotechnologies

[14] University of Naples “Federico II”,Department of Clinical and Biological Sciences

[15] CEINGE-Biotecnologie Avanzate scarl,undefined

[16] Scientific Direction,undefined

[17] IRCCS-CROB,undefined

[18] University of Turin,undefined

来源：

Cellular Oncology | 2017年 / 40卷

关键词：

Multiple myeloma; Plasma cells; EphA3; Cell movement; Anti EphA3 monoclonal antibody;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：483 / 496

页数：13

共 50 条

[41] Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions [J].

Seiichi Okabe ;

Yuko Tanaka ;

Akihiko Gotoh .

Biomarker Research, 10

[42] Therapeutic targeting of PFKFB3 and PFKFB4 in multiple myeloma cells under hypoxic conditions [J].

Okabe, Seiichi ;

Tanaka, Yuko ;

Gotoh, Akihiko .

BIOMARKER RESEARCH, 2022, 10 (01)

[43] Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway [J].

Li, Mei ;

Chen, Cailong ;

Wang, Qian ;

Jiang, Xiaolu ;

Tan, Lanlan ;

Huang, Ying ;

Zhang, Yan ;

Zhang, Zubin .

CANCER CELL INTERNATIONAL, 2021, 21 (01)

[44] Glaucocalyxin A suppresses multiple myeloma progression in vitro and in vivo through inhibiting the activation of STAT3 signaling pathway [J].

Mei Li ;

Cailong Chen ;

Qian Wang ;

Xiaolu Jiang ;

Lanlan Tan ;

Ying Huang ;

Yan Zhang ;

Zubin Zhang .

Cancer Cell International, 21

[45] The Effect of miR-361-3p Targeting TRAF6 on Apoptosis of Multiple Myeloma Cells [J].

Fan, Zhen ;

Wu, Zhiwei ;

Yang, Bo .

JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, 31 (02) :197-206

[46] Reelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3 [J].

Lin, Liang ;

Yan, Fan ;

Zhao, Dandan ;

Lv, Meng ;

Liang, Xiaodong ;

Dai, Hui ;

Qin, Xiaodan ;

Zhang, Yan ;

Hao, Jie ;

Sun, Xiuyuan ;

Yin, Yanhui ;

Huang, Xiaojun ;

Zhang, Jun ;

Lu, Jin ;

Ge, Qing .

ONCOTARGET, 2016, 7 (09) :9844-9858

[47] MicroRNA-125a/b-5p promotes malignant behavior in multiple myeloma cells and xenograft tumor growth by targeting DIS3 [J].

Zhang, Ting ;

Wang, Lan-Lan ;

Guan, Jun ;

Zhou, Ying ;

Cheng, Ping ;

Zou, Liang .

KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2022, 38 (06) :574-584

[48] Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo [J].

T Kiziltepe ;

J D Ashley ;

J F Stefanick ;

Y M Qi ;

N J Alves ;

M W Handlogten ;

M A Suckow ;

R M Navari ;

B Bilgicer .

Blood Cancer Journal, 2012, 2 :e64-e64

[49] Rationally engineered nanoparticles target multiple myeloma cells, overcome cell-adhesion-mediated drug resistance, and show enhanced efficacy in vivo [J].

Kiziltepe, T. ;

Ashley, J. D. ;

Stefanick, J. F. ;

Qi, Y. M. ;

Alves, N. J. ;

Handlogten, M. W. ;

Suckow, M. A. ;

Navari, R. M. ;

Bilgicer, B. .

BLOOD CANCER JOURNAL, 2012, 2 :e64-e64

[50] Cyclized Oligopeptide Targeting LRP5/6-DKK1 Interaction Reduces the Growth of Tumor Burden in a Multiple Myeloma Mouse Model [J].

Park, Bo Mi ;

Kim, Eun Jin ;

Nam, Hee Jin ;

Zhang, Dongdong ;

Bae, Chu Hyun ;

Kang, Myeongmo ;

Kim, Heeyoun ;

Lee, Weontae ;

Bogen, Bjarne ;

Lim, Sung-Kil .

YONSEI MEDICAL JOURNAL, 2017, 58 (03) :505-513

← 1 2 3 4 5 →